Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS
NCT00505401
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
BIOLOGICAL:
recombinant HIV-1 Tat protein
Sponsor
Istituto Superiore di Sanità